Great Valley Advisor Group Inc. reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,923 shares of the healthcare conglomerate's stock after selling 1,039 shares during the quarter. Great Valley Advisor Group Inc.'s holdings in UnitedHealth Group were worth $20,195,000 at the end of the most recent quarter.
Several other large investors have also made changes to their positions in UNH. Western Pacific Wealth Management LP raised its stake in UnitedHealth Group by 2.2% in the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock valued at $456,000 after purchasing an additional 19 shares in the last quarter. Axiom Financial Strategies LLC boosted its position in UnitedHealth Group by 3.6% in the fourth quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate's stock valued at $291,000 after buying an additional 20 shares in the last quarter. Richwood Investment Advisors LLC increased its holdings in shares of UnitedHealth Group by 0.4% during the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after buying an additional 20 shares in the last quarter. Prentice Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 0.8% in the 4th quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate's stock valued at $1,278,000 after acquiring an additional 21 shares during the last quarter. Finally, 44 Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 1.6% in the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate's stock valued at $662,000 after acquiring an additional 21 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.
UnitedHealth Group Price Performance
Shares of UnitedHealth Group stock traded down $0.58 during trading on Tuesday, hitting $294.99. 20,069,744 shares of the stock traded hands, compared to its average volume of 6,655,522. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm's fifty day moving average is $448.25 and its 200-day moving average is $501.48. The stock has a market cap of $267.60 billion, a price-to-earnings ratio of 19.03, a PEG ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the previous year, the company earned $6.91 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
Insider Activity
In other news, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction dated Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO John F. Rex bought 17,175 shares of the stock in a transaction dated Friday, May 16th. The stock was purchased at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the purchase, the chief financial officer now owns 203,796 shares in the company, valued at $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.33% of the company's stock.
Wall Street Analysts Forecast Growth
UNH has been the topic of several research reports. Wolfe Research reduced their price target on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a report on Tuesday, May 20th. Morgan Stanley dropped their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Royal Bank of Canada cut their target price on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. Raymond James lowered shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. Finally, Wall Street Zen lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and a consensus target price of $441.87.
Check Out Our Latest Stock Report on UNH
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.